The International Vaccine Institute, with a $34 million grant from the Samsung Foundation to support development in the field, is fully funding the Inovio-GeneOne Korean trial.
Hyundai Pharm has filed for the marketing approval of Natesto, a nasal gel formulation of testosterone, with South Korea’s Ministry of Food and Drug Safety (MFDS).
The exclusive ten-year agreement includes a minimum of $2 million per year in sales of Zestra to the Company for a total of $20 million over the life of the ten-year term of the agreement